Del Monte Corporation Chairman and CEO Mohammad Abu-Ghazaleh joined Bloomberg Open Interest to explain why the iconic food brand reunited after nearly four decades and discusses easing supply chain pressures. He also reveals some surprising pharmaceutical research using pineapple-derived compounds (Source: Bloomberg)
Trending
- Kraft Heinz Trades at a Fraction of PepsiCo’s Valuation. Is the Discount Deserved?
- LexisNexis Launches AI Tool That Adapts to Changing Fraud Patterns
- 10-year Treasury yields stay near 5%, what would trigger the next break higher?
- Princeton’s 15-year run as the nation’s top college is over. MIT is now No. 1.
- The OeNB’s Martin Kocher on the Eurosystem’s inflation outlook
- Fortenova to sell Serbian retail businesses to Alta Retail
- Kylie Jenner sells California mansion for $5 million below asking
- My husband and I are in our 50s and have no kids. We have $2 million. Do we need a will?

